EUVIMEDEUVIMED entdecken
VergleichsstudieNetzwerk-MetaanalyseSystematische Übersicht

Effectiveness of anti-osteoporotic medications in the management of glucocorticoid-induced osteoporosis: a systematic review and network meta-analysis on behalf of the ECTS clinical action group

Maria P Yavropoulou iD, Marieke M Ter Wee iD, Anda Mihaela Naciu iD, Julien Paccou iD, Athanasios D Anastasilakis iD, Chrysoula G Gialouri iD, Barbara Hauser iD, Anne Sophie Sølling iD, Stella D'Oronzo iD, Tim Rolvien iD, Willem F Lems iD

European Journal of Endocrinology · 03.08.2026 · 195 (2) · S1-S21

DOI: 10.1093/ejendo/lvag147 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Endocrinology, online erschienen am 07.08.2026. Verfasst von Maria P Yavropoulou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Unit, First Department of Propaedeutic and Internal Medicine, LAIKO University Hospital, Medical School, National and Kapodistrian Univ…. Hauptthemen laut MEDLINE: Osteoporosis, Bone Density Conservation Agents, Bone Density, Glucocorticoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate and compare the efficacy of anti-osteoporotic-medications (AOM) for the prevention and treatment of glucocorticoid-induced-osteoporosis (GIOP).

Design

Systematic review and network-meta-analysis conducted in accordance with PRISMA-NMA guidelines (ProsperoID: CRD42024502298).

Methods

MEDLINE, Embase, and Web of Science were searched from inception to December 2025 to identify randomized-controlled-trials and comparative-observational-studies evaluating AOM in adults receiving oral glucocorticoids (GC). Outcomes included percentage change in areal bone- mineral-density (aBMD) at the lumbar-spine (primary), femoral-neck, and total-hip. A random effects network-meta-analysis was performed, integrating direct and indirect comparisons across AOM. Certainty of evidence was assessed using the CINeMA framework.

Results

Thirty-one studies (28 randomized-controlled-trials and 3 observational-studies) involving 5260 participants (age-range: 29.6-70.6 years, 72.5% females) were included. All AOM were superior to placebo or calcium/vitaminD supplementation in increasing lumbar-spine aBMD. Teriparatide demonstrated the greatest efficacy compared with alendronate (effect-size: 3.8; 95% CI: 2.9-4.6), risedronate (4.0; 95% CI: 2.9-5.1), denosumab (1.5; 95% CI: 0.1-2.9), and zoledronate (2.4; 95% CI: 1.1-3.6), while no significant difference was observed with romosozumab (0.3; 95% CI: −2.1 to 1.4). Among antiresorptive-medications, zoledronate and denosumab showed greater efficacy than oral bisphosphonates, which demonstrated modest positive effects. In sensitivity analyses restricted to established GIOP, defined as GC users ≥3months, teriparatide and romosozumab remained superior to antiresorptive-medications. Evidence for total-hip and femoral-neck aBMD outcomes was limited by substantial network inconsistency (mostly missing data). Included studies were underpowered to assess difference in fracture outcomes.

Conclusions

This network-meta-analysis demonstrates a clear gradient of efficacy among AOM in GIOP, with anabolic and potent antiresorptive-medications producing the largest gains in lumbar-spine aBMD supporting current ECTS recommendations advocating risk-stratified treatment selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisBone Density Conservation AgentsBone DensityGlucocorticoidsTreatment OutcomeLumbar VertebraeFemur NeckPelvic BonesHumansMaleAdultMiddle AgedAged

Stichwörter der Autor:innen

bisphosphonatesdenosumabglucocorticoidsosteoporosisromosozumabteriparatidezoledronate

Substanzen

Bone Density Conservation AgentsGlucocorticoids

Autor:innen und Institutionen

  • Endocrinology Unit, First Department of Propaedeutic and Internal Medicine, LAIKO University Hospital, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.
  • Department of Epidemiology and Data Science, Amsterdam UMC, location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam 1081, The Netherlands.
  • Amsterdam Public Health Research Institute, Societal Participation, Amsterdam 1081 BT, The Netherlands.
  • Unit of Osteometabolic and Thyroid Diseases, Fondazione Policlinico Universitario Campus Bio-Medico, Rome 00128, Italy.
  • University of Lille, CHU Lille, MABlab ULR 4490, Department of Rheumatology, Lille F-59000, France.
  • Department of Endocrinology, 424 General Military Hospital, Thessaloniki 56429, Greece.

ORCID-Profile: Maria P Yavropoulou, Marieke M Ter Wee, Anda Mihaela Naciu, Julien Paccou, Athanasios D Anastasilakis, Chrysoula G Gialouri, Barbara Hauser, Anne Sophie Sølling, Stella D'Oronzo, Tim Rolvien, Willem F Lems

Zitieren

APA

Yavropoulou, M. P., Ter Wee, M. M., Naciu, A. M., Paccou, J., Anastasilakis, A. D., Gialouri, C. G., Hauser, B., Sølling, A. S., D'Oronzo, S., Rolvien, T., & Lems, W. F. (2026). Effectiveness of anti-osteoporotic medications in the management of glucocorticoid-induced osteoporosis: a systematic review and network meta-analysis on behalf of the ECTS clinical action group. European Journal of Endocrinology, 195(2), S1-S21. https://doi.org/10.1093/ejendo/lvag147

Vancouver

Yavropoulou MP, Ter Wee MM, Naciu AM, Paccou J, Anastasilakis AD, Gialouri CG, et al. Effectiveness of anti-osteoporotic medications in the management of glucocorticoid-induced osteoporosis: a systematic review and network meta-analysis on behalf of the ECTS clinical action group. European Journal of Endocrinology. 2026;195(2):S1-S21. doi:10.1093/ejendo/lvag147

BibTeX
@article{Yavropoulou2026,
  author = {Yavropoulou, Maria P and Ter Wee, Marieke M and Naciu, Anda Mihaela and Paccou, Julien and Anastasilakis, Athanasios D and Gialouri, Chrysoula G and Hauser, Barbara and Sølling, Anne Sophie and D'Oronzo, Stella and Rolvien, Tim and Lems, Willem F},
  title = {Effectiveness of anti-osteoporotic medications in the management of glucocorticoid-induced osteoporosis: a systematic review and network meta-analysis on behalf of the ECTS clinical action group},
  journal = {European Journal of Endocrinology},
  year = {2026},
  volume = {195},
  number = {2},
  pages = {S1--S21},
  doi = {10.1093/ejendo/lvag147}
}
Kostenlos starten →